Emyria logo
EMD

Emyria

Health Care Equipment & Services

Emyria operates a network of specialist medical clinics focused on collecting and commercializing clinical data. The company leverages proprietary software to gather anonymized patient data, which is then used to generate clinical evidence. This positions Emyria uniquely in the healthcare sector, combining medical services with data-driven insights.

Short position

short percentage0.00%
reported shorts6.4K
shares on issue806.686M

Emyria (ASX:EMD) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 6,369 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.10% in February 2020. EMD is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Emyria (EMD) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency

Revenue
$4.1M (source: ASX (Markit))vs $1.4M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 29 Sep 2026
NPAT
−$6.1M (source: ASX (Markit))vs −$3.1M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 29 Sep 2026
EPS (diluted)
−$0.008 (source: Derived: trailing 12 months at year end)vs −$0.007 (FY25)
Derived: trailing 12 months at year end, as at 29 Sep 2026
Rev YoY
+190.6%FY
EPS YoY
n/aTTM
  • ASX (Markit)
  • Derived: trailing 12 months at year end

Key ratios

Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 9 Oct 2026

Gross margin
n/a
Operating margin
n/a
Net margin
−150.8%
FCF margin
n/a
ROE
n/a
ROA
n/a
FCF conversion
n/a
Net debt (excl. leases)
n/a
Net debt / EBITDA
n/a
Current ratio
n/a
Interest cover
n/a
Cash dividends paid / net profit
n/a
Market cap
n/a (no share count we can vouch for)
P/E
n/a
P/B
n/a (no share count we can vouch for)

Ratios use the reporting currency (AUD); market cap is in AUD. Source: ASX (Markit), as at 29 Sep 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

EMD income, newest period first, figures in AUD
Line itemFY26FY25FY24FY23
Revenue$4.1M (source: ASX (Markit))$1.4M (source: ASX (Markit))$2.2M$1.6M
Gross profitn/an/a−$167.5K−$647.5K
Operating incomen/an/a−$6.9M−$7.1M
EBITDAn/an/a−$10.5M−$4.6M
EBITn/an/a−$11.2M−$5.0M
Interest expensen/an/a$253.3K$128.8K
Pretax incomen/an/a−$11.5M−$5.1M
Taxn/an/a$0$0
NPAT−$6.1M (source: ASX (Markit))−$3.1M (source: ASX (Markit))−$11.5M−$5.1M
Net interest incomen/an/a−$231.7K−$98.5K
EPS basic−$0.008 (source: Derived: trailing 12 months at year end)−$0.007−$0.032−$0.018
EPS diluted−$0.008 (source: Derived: trailing 12 months at year end)−$0.007−$0.032−$0.018
Sharesn/an/a409.0M310.6M
  • ASX (Markit)
  • Derived: trailing 12 months at year end